(Q37853577)

24 August 2017

1 reference

title

Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury (English)

1 reference

24 August 2017

Shigeko Inokuma

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

17 March 2011

1 reference

Expert Opinion on Drug Safety

24 August 2017

published in

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

603-611

1 reference

Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Leflunomide-Induced Pneumonitis in a Patient with Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Lethal pneumonitis under leflunomide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Clinical expression of leflunomide-induced pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer - a retrospective analysis: JMTO LC03-02

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.560835

10.1517/14740338.2011.560835

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference